CS logo
small CS logo
Natalie Warren Bryant Cancer Center at St. Francis Hospital

Tulsa, Oklahoma, United States
Cancer treatment center in Tulsa, Oklahoma
11212 E 48th St, Tulsa, OK 74146

About Natalie Warren Bryant Cancer Center at St. Francis Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
40
Radiation Therapy Oncology Group
17
Eastern Cooperative Oncology Group
16
NSABP Foundation Inc
12
Children's Oncology Group
11
Gynecologic Oncology Group
8
SWOG Cancer Research Network
5
ECOG-ACRIN Cancer Research Group
2
National Cancer Institute (NCI)
2
North Central Cancer Treatment Group
1
University of South Florida
1
Total Rows: 11

Clinical Trials at Natalie Warren Bryant Cancer Center at St. Francis Hospital


During the past decade, Natalie Warren Bryant Cancer Center at St. Francis Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 55 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 9 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First Remission
1993-04-01
Completed
1,929
Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia
1996-06-01
2012-03-01
Completed
221
Piritrexim in Treating Patients With Advanced Cancer of the Urinary Tract
1997-05-01
2004-03-01
Completed
40
Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
1997-05-01
2006-03-01
Completed
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
1997-08-01
Terminated
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
1997-12-01
2004-09-01
Completed
Combination Chemotherapy After Surgery in Treating Patients With Cancer of the Esophagus or Stomach
1998-03-01
Completed
55

Rows per page:

1–100 of 115

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 40 trials, followed by "Radiation Therapy Oncology Group" with 17 trials sponsored, "Eastern Cooperative Oncology Group" with 16 trials sponsored, "NSABP Foundation Inc" with 12 trials sponsored and "Children's Oncology Group" with 12 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 113 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 18 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAlliance for ClinicalTrials in Oncology: 40Alliance for ClinicalTrials in Oncology: 40Radiation TherapyOncology Group: 17Radiation TherapyOncology Group: 17Eastern CooperativeOncology Group: 16Eastern CooperativeOncology Group: 16NSABP Foundation Inc: 12NSABP Foundation Inc: 12Children's Oncology Group: 11Children's Oncology Group: 11Gynecologic Oncology Group: 8Gynecologic Oncology Group: 8SWOG Cancer ResearchNetwork: 5SWOG Cancer ResearchNetwork: 5ECOG-ACRIN CancerResearch Group: 2ECOG-ACRIN CancerResearch Group: 2National Cancer Institute (NCI): 2National Cancer Institute (NCI): 2North Central CancerTreatment Group: 1North Central CancerTreatment Group: 1

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 113National CancerInstitute (NCI): 113NRG Oncology: 12NRG Oncology: 12Cancer and LeukemiaGroup B: 5Cancer and LeukemiaGroup B: 5North Central CancerTreatment Group: 5North Central CancerTreatment Group: 5SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3NCIC Clinical Trials Group: 2NCIC Clinical Trials Group: 2Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2American College ofSurgeons: 1American College ofSurgeons: 1Astellas Pharma Inc: 1Astellas Pharma Inc: 1

Clinical Trials Conditions at Natalie Warren Bryant Cancer Center at St. Francis Hospital


According to Clinical.Site data, the most researched conditions in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are "Breast Cancer" (25 trials), "Lung Cancer" (15 trials), "Leukemia" (9 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (9 trials) and "Colorectal Cancer" (8 trials). Many other conditions were trialed in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Natalie Warren Bryant Cancer Center at St. Francis Hospital


Most popular intervention types in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are "Drug" (96 trials), "Radiation" (31 trials), "Other" (29 trials), "Biological" (28 trials) and "Procedure" (19 trials). Other intervention types were less common.
The name of intervention was led by "placebo" (17 trials), "cyclophosphamide" (14 trials), "radiation therapy" (14 trials), "gemcitabine hydrochloride" (9 trials) and "paclitaxel" (9 trials). Other intervention names were less common.

Clinical Trials Genders at Natalie Warren Bryant Cancer Center at St. Francis Hospital


The vast majority of trials in "Natalie Warren Bryant Cancer Center at St. Francis Hospital" are 86 trials for "All" genders, 24 trials for "Female" genders and 5 trials for "Male" genders.

Clinical Trials Status at Natalie Warren Bryant Cancer Center at St. Francis Hospital


Currently, there are NaN active trials in "Natalie Warren Bryant Cancer Center at St. Francis Hospital". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Natalie Warren Bryant Cancer Center at St. Francis Hospital, undefined suspended trials, and 11 terminated clinical trials to date.
Out of the total trials that were conducted in Natalie Warren Bryant Cancer Center at St. Francis Hospital, 6 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 52Phase 2: 52Phase 3: 50Phase 3: 50Phase 1: 6Phase 1: 6Not Applicable: 5Not Applicable: 5

Created with Highcharts 11.1.0Trials StatusCompleted: 95Completed: 95Terminated: 11Terminated: 11Active, not recruiting: 8Active, not recruiting: 8Unknown status: 1Unknown status: 1